Fresenius Kabi's approved generic therapy addresses acute symptomatic hypocalcemia and targets a US market valued at nearly $71 million
Conceptualized as an aggregator platform it integrates existing programme systems through an API-based federated architecture
The private funding rose 38% amid growing international collaborations and CDMO demand
Approval expands Lupin’s specialty portfolio in the US market for treatment of urea cycle disorders
Enterprise-scale adoption in 2026 will be driven by domain-specific AI, compliance automation, and strong digital foundations across quality, manufacturing and regulatory workflows
Compared to a net loss of Rs 12 crore in FY25, the pharma major reported a consolidated turnaround in its financial performance
Tamir brings more than 20 years of experience in the medical technology sector
Both join the leading CRDMO’s executive committee to drive global people strategy and commercial expansion
Gambhir brings over 35 years of rich experience in strategic finance, governance, business transformation, and leadership
The medtech firm strengthens its full-stack remote cardiac monitoring platform, achieves 11x revenue growth, and advances its global expansion plans
Subscribe To Our Newsletter & Stay Updated
